We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combining Tests Leads to Better Prediabetes Detection

By LabMedica International staff writers
Posted on 16 Dec 2015
Print article
Image: Steps in the oral glucose tolerance test; if the blood sugar level is 140 to 199 mg/dL, the person has prediabetes or impaired glucose tolerance (IGT) (Photo courtesy of Penn Medicine).
Image: Steps in the oral glucose tolerance test; if the blood sugar level is 140 to 199 mg/dL, the person has prediabetes or impaired glucose tolerance (IGT) (Photo courtesy of Penn Medicine).
The application of a screening test that is both robust and handy is vital for promptly ascertaining subjects with prediabetes. A robust and quick prediabetes diagnostic test can reduce overall societal costs of diabetes by motivating subjects with prediabetes to seek diabetes preventative care.

Fasting plasma glucose (FPG) and oral glucose tolerance (OGT) tests are greatly used in screening and diagnosing type 2 diabetes and while the OGT test is mostly recognized as the benchmark for diagnosing type 2 diabetes, but the test is laborious and uncomfortable to patients.

Scientists at Georgia State University (Atlanta, GA, USA) studied a group of participants whose ages ranged from 12 to 75 years with no missing values for age, height, weight, and assayed for OGT, FPG and HbA1c. Subjects were categorized as nondiabetic if they had FPG of less than 25 mg/dL or FPG of less than 199 mg/dL on a two-hour OGT test and HbA1c less than 6.5%. Prediabetes comprises impaired fasting glucose (IFG) expressed as FPG 100–125 mg/dL, impaired glucose tolerance (IGT) as OGT of 140–199 mg/dL, and HbA1c 5.7–6.4%.

The scientists found that the joint use of FPG and HbA1c test was associated with significantly higher proportion of subjects with prediabetes across age, race/ethnicity and BMI as compared to combined use of OGT and FPG, OGT and HbA1c. Overall prevalence of prediabetes using OGT + FPG, OGT + HbA1c, HbA1c + FPG, and OGT + FPG + HbA1c tests were 20.3%, 24.2%, 33%, and 34.3%, respectively. The study indicates prediabetes rates were higher using HbA1c + FPG tests compared to the traditionally used OGT + FPG tests.

The authors concluded that using a combination of HbA1c and FPG test in screening for prediabetes provides the benefits of individual test and decreases the risk of systematic bias inherent in using only HbA1c testing. This study proposes the need to redefine a basic and a practical way on the application of HbA1cin screening for prediabetes. The use of HbA1c test in detection of prediabetes in population and clinical settings should take into account patient race/ethnicity, gender, age, and body mass index (BMI). The study was published November 20, 2015, in the journal Frontiers in Public Health.

Related Links:

Georgia State University 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.